HOME › Press Releases › BRIC Diagnostic Imaging Equipment Market worth $7.6 Billion by 2018
BRIC Diagnostic Imaging Equipment Market worth $7.6 Billion by 2018
The report “Diagnostic Imaging Equipment Market by Modality [Digital X-ray Imaging, Ultrasound (Color Doppler, Portable), Magnetic Resonance Imaging, CT Scanner (Low-, Mid-, & High-end), Mammography, PET, SPECT] - Emerging Markets (BRIC - Brazil, Russia, India, and China)- 2011-2018” analyzes and studies the major market drivers, restraints, opportunities, and challenges in Brazil, Russia, India, and China.
Browse 103 market data tables and 46 figures spread through 191 pages and in-depth TOC on “Diagnostic Imaging Equipment Market by Modality [Digital X-ray Imaging, Ultrasound (Color Doppler, Portable), Magnetic Resonance Imaging, CT Scanner (Low-, Mid-, & High-end), Mammography, PET, SPECT] - Emerging Markets (BRIC - Brazil, Russia, India, and China) - 2011-2018”
Early buyers will receive 10% customization on reports.
This report studies the BRIC diagnostic imaging equipment market over the forecast period of 2013 to 2018. The market is expected to reach ~$7.6 billion by 2018, at CAGR of 10.5% from 2013 to 2018.
Based on type of modality, the BRIC diagnostic imaging equipment market is divided into six segments, namely, ultrasound systems, X-ray imaging systems, computed tomography (CT) systems, magnetic resonance imaging (MRI) systems, nuclear imaging systems (comprise SPECT and PET systems), and mammography systems. Each is further sub-segmented based on product type. The ultrasound systems market is sub-segmented by technology (color Doppler ultrasound imaging systems and black & white ultrasound imaging systems) and portability (trolley-based and compact/portable ultrasound imaging systems). The X-ray imaging systems market is also sub-segmented by technology (analog X-ray imaging systems and digital X-ray imaging systems (computed radiography and direct radiography)) and portability (stationary X-ray imaging systems and portable X-ray imaging systems). The MRI systems market is divided by architecture (closed MRI and open MRI) and field strength (high-field MRI systems, very high-field MRI systems, and low-to-mid-field MRI systems). Mammography systems are segmented on the basis of technology (analog mammography and digital mammography). Likewise, the market for CT scanners is further segmented on the basis of slice type (mid-end, low-end, and high-end slice CT scanners).
A number of factors such as increasing public and private funding for the development of healthcare facilities, increasing awareness about early-stage diagnosis of diseases, rising patient population, and growing launches of low-cost and technologically advanced diagnostic imaging systems are driving the growth of the BRIC diagnostic imaging equipment market. However, factors such as high cost of diagnostic imaging systems, side-effects of radiations, and financial budget constraints with small and medium sized healthcare service providers are restraining the growth of the BRIC diagnostic imaging equipment market. Furthermore, the rising demand for refurbished systems and stringent tax policies are major challenges faced by market players in BRIC countries.
As of 2013, China held the largest share, 45%, of the BRIC diagnostic imaging equipment market, followed by Russia. The Chinese market is also expected to grow at the fastest CAGR of 12.0% from 2013 to 2018. A number of factors such as ongoing healthcare reforms, growing government investments to develop its healthcare infrastructure in rural areas, and favorable demographic scenario (huge patient pool and rapidly aging population) are boosting the growth of diagnostic imaging equipment market in China. However, irregularities in the tendering process and government price controls over medical devices are some key challenges faced by players in the Chinese diagnostic imaging equipment market.
The major players in the BRIC diagnostic imaging equipment market include GE Healthcare (U.K.), Hitachi Medical Corporation (Japan), Hologic, Inc. (U.S.), Philips Healthcare (Netherlands), Samsung Medison (South Korea), Siemens Healthcare (Germany), Shimadzu Corporation (Japan), and Toshiba Medical Systems Corporation (Japan).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252